Retroviral Therapeutics

Antiretroviral drugs are the medications for treatment of infection by retroviruses, primarily HIV. Different classes of antiretroviral drugs act at different stages of HIV life cycle. The Combination of several (typically three or four) antiretroviral drugs is known as Highly Active Anti-Retroviral Therapy (HAART).

 

HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death

  • Highly Active Anti-Retroviral therapy (HAART)
  • Anti-Retroviral (ARV) Therapies
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
  • International Funding on Antiretroviral drugs
  • Retrovirology Market Analysis
  • ART Drug Discoveries

Related Conference of Retroviral Therapeutics

October 21-22, 2019

15th World Congress on Infection Prevention and Control

ZURICH | SWITZERLAND Venue: Movenpick Hotel Zürich Airport
November 25-26, 2019

2nd World Congress on Rare Diseases

Dubai, UAE
January 27-28, 2020

3rd Global Experts Meeting on Infectious Diseases

| Bangkok, Thailand
February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
March 11-12, 2020

8th International Conference on HIV AIDS STD & STIs

Barcelona, Spain
March 27-28, 2020

5th Annual Congress on Infectious Diseases

Barcelona, Spain
May 18-19, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
October 05-06, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
October 12-13, 2020

7th International Conference on Infectious Diseases & Antibiotics

Prague, Czech republic
September 28-29, 2020

13th Global Infections Conference

| Singapore
December 06-07, 2021

3rd World Congress on Rare Diseases

Dubai, UAE

Retroviral Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in